Akamai Tech REITERATED at Hold and 2 Must-See Reiterated Ratings

July 26, 2012

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on July 26th.

AMAG Pharma (NASDAQ:AMAG): Ladenburg Thalmann reiterated its rating of Buy for this company and changed its price target from $15 to $17.5.

Don’t Miss: Why is Zynga CRASHING?

Zynga (NASDAQ:ZNGA): Canaccord Genuity reiterated its rating of Hold for this company and changed its price target from $13 to $6.

Akamai Tech (NASDAQ:AKAM): Canaccord Genuity reiterated its rating of Hold for this company and changed its price target from $32 to $34. FBR Capital reiterated its rating of Mkt Perform for this company and changed its price target from $32 to $35.

Don’t Miss: American Express Stock: Buy, Sell, or Stay Away?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com